Clinical Trials

Empowering Lives: Advancements in Chronic Lymphocytic Leukemia

4 Comments / Chronic lymphoblastic leukemia, Clinical Trials, English, Leukemia, Treatment

Join us as we sit down with Dr. Deborah Stephens from the University of Utah, as we discover the latest breakthroughs in treating chronic lymphocytic leukemia (CLL).  We also gain valuable insights into enhancing patient’s quality of life In this episode, Dr. Stephens emphasizes the importance of effective communication with your healthcare team, unveiling strategies […]

Empowering Lives: Advancements in Chronic Lymphocytic Leukemia Read More »

Accelerating Hope for Aggressive Non-Hodgkin Lymphoma

1 Comment / Clinical Trials, English, Lymphoma, Non-Hodgkin lymphoma, Treatment

Delve into the complex landscape of non-Hodgkin lymphoma research, where a cure is pursued amidst a backdrop of over 100 subtypes of this disease. In this episode, Dr. Kieron Dunleavy, of MedStar Georgetown University Hospital, breaks down the differences in treatments, prognosis and goals for both slow-growing and aggressive subtypes of non-Hodgkin lymphoma. Discover the

Accelerating Hope for Aggressive Non-Hodgkin Lymphoma Read More »

Treating Rare Disease with Compassion: Chronic Myelomonocytic Leukemia (CMML)

Leave a Comment / Chronic Myelomonocytic Leukemia, Clinical Trials, English, Leukemia, Treatment

While chronic myelomonocytic leukemia (CMML) is a rare disease, it is not rare to the patients and loved ones who are affected by it. In this episode, Dr. Mrinal Patnaik of the Mayo Clinic in Rochester, MN, discusses the unique aspects of CMML and how it is classified and treated.  Dr. Patnaik shares the latest

Treating Rare Disease with Compassion: Chronic Myelomonocytic Leukemia (CMML) Read More »

Living A Full Life: Exploring Myeloproliferative Neoplasms (MPNs)

Leave a Comment / Clinical Trials, English, Myeloproliferative Neoplasms (MPN), Polycythemia Vera (PV), Treatment

Myeloproliferative Neoplasms (MPNS) is an umbrella term that includes myelofibrosis (MF), essential thrombocythemia (ET) and polycythemia vera (PV). In this episode, Dr. Angela Fleischman of the Chao Comprehensive Cancer Center in Orange, CA, delves into these disorders in more detail. She shares how a patient’s quality of life can be improved with the latest advancements

Living A Full Life: Exploring Myeloproliferative Neoplasms (MPNs) Read More »

Attacking the Cancer Cell: Advances in CAR T-Cell Therapy

5 Comments / Chimeric antigen receptor (CAR) t-cell therapy, Clinical Trials, English, Treatment

Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial Healthcare System in Pembroke Pines, Florida. In this episode, we explore the latest advances and what the future holds for CAR T-cell therapy.    This comprehensive view of CAR T-cell therapy will give blood cancer

Attacking the Cancer Cell: Advances in CAR T-Cell Therapy Read More »

Hopeful Advancements for Chronic Myeloid Leukemia (CML)

5 Comments / Chronic myeloid leukemia, Clinical Trials, English, Treatment

Join us as we speak to Dr. Richard Larson and Dr. Anand Patel from University of Chicago Medicine about chronic myeloid leukemia (CML). In this episode, they discuss the latest advances in treatment for CML and what is on the horizon. With decades of progress with targeted treatments, CML patients are now given more hope

Hopeful Advancements for Chronic Myeloid Leukemia (CML) Read More »

Statistics Don’t Color My Outcome: A CAR T-cell Therapy Success

5 Comments / Chimeric antigen receptor (CAR) t-cell therapy, Clinical Trials, English, Non-Hodgkin lymphoma

Join us as we speak to Laurie Adami, a follicular lymphoma (non-Hodgkin lymphoma) survivor. In this episode, Laurie shares her long journey through multiple cancer treatments, which eventually led to CAR T-cell therapy and complete remission. Hear one patient’s story of hope, as new treatments continued to come out, keeping her stable until the one

Statistics Don’t Color My Outcome: A CAR T-cell Therapy Success Read More »

Instilling Hope Through Progress: Myelodysplastic Syndromes (MDS)

1 Comment / Clinical Trials, English, Myelodysplastic Syndromes (MDS), Treatment

Join us as we speak to Dr. Anand Patel and Dr. Satyajit Kosuri from The University of Chicago Medicine about the latest treatment advances for myelodysplastic syndromes (MDS). In honor of MDS Awareness Day on October 25th, the doctors discuss how MDS develops, why genetic mutations matter when choosing a treatment course, and how stem

Instilling Hope Through Progress: Myelodysplastic Syndromes (MDS) Read More »

Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL)

5 Comments / Chimeric antigen receptor (CAR) t-cell therapy, Chronic lymphoblastic leukemia, Clinical Trials, English

Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses current treatments for chronic lymphocytic leukemia (CLL) and the exciting possibilities for the future using immunotherapies. Dr. Davids shares how the goal of treatment is long term remission and quality of life. Since 2010, BTK

Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL) Read More »

Let’s Talk About Stem Cell Transplantation: Benefits and Side Effects

9 Comments / Clinical Trials, English, Treatment

Please join us as we speak to Dr. Shernan Holtan and guest co-host from LLS, Christina Neilsen. In this episode, Dr. Holtan discusses stem cell transplants; how they work, the different types of transplants, and the side effects, including graft-vs-host disease (GVHD). Dr. Holtan shares exciting new research on reducing GVHD and provides blood cancer

Let’s Talk About Stem Cell Transplantation: Benefits and Side Effects Read More »

Myelodysplastic Syndromes (MDS): A Group of Diseases

5 Comments / Clinical Trials, English, Myelodysplastic Syndromes (MDS), Treatment

Please join us as we speak to Dr. Daniel Pollyea from the University of Colorado School of Medicine.  In this episode, Dr. Pollyea discusses the group of diseases that make up Myelodysplastic Syndromes (MDS) and how their variability leads to different treatments and prognoses, from active monitoring to chemotherapy and/or stem cell transplantation.  He shares

Myelodysplastic Syndromes (MDS): A Group of Diseases Read More »

Patient-Doctor Perspectives: Hope in the Uncertainty of AML

3 Comments / Acute myeloid leukemia, Advocacy, Chimeric antigen receptor (CAR) t-cell therapy, Clinical Trials, English, Leukemia, Survivorship

Join us as we speak with Charles Huang and Dr. Gabriel Mannis in honor of AML Awareness Day (April 21st). In this episode, Charles tells us about his treatment for AML, participation in clinical trials, and shares about his struggle to find a bone marrow donor as an Asian Pacific Islander. Charles then turned his

Patient-Doctor Perspectives: Hope in the Uncertainty of AML Read More »

Innovative Therapies for Acute Leukemias

Leave a Comment / Acute lymphoblastic leukemia, Acute myeloid leukemia, Children and young adults, Clinical Trials, English, Treatment

Join us as we speak to Dr. Hongtao Liu and Dr. Adam DuVall from University of Chicago Medicine, about current and emerging cellular therapies for acute leukemias. These innovative therapies include CAR T-cell therapy, modified Natural Killer (NK) cells and stem cell transplantations. In this episode, we discuss how these groundbreaking therapies have changed the

Innovative Therapies for Acute Leukemias Read More »

Under the MPN Umbrella: Exploring Myelofibrosis

1 Comment / Clinical Trials, English, Myeloproliferative Neoplasms (MPN)

Join us as we speak to Dr. Brady Stein, a clinical hematologist and researcher at the Northwestern University Feinberg School of Medicine in Chicago, IL. In this episode, Dr. Stein discusses the rare blood cancer, myelofibrosis (MF), which is a type of myeloproliferative neoplasms (MPNs). Hear about the unique characteristics of MF, how it develops,

Under the MPN Umbrella: Exploring Myelofibrosis Read More »

Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Leave a Comment / BPDCN, Chimeric antigen receptor (CAR) t-cell therapy, Clinical Trials, English

Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell Park Comprehensive Cancer Center in Buffalo, NY. In this episode, Dr. Wang delves into the rare blood cancer, blastic plasmacytoid dendritic cell neoplasm (BPDCN). Usually identified by characteristic deep purple lesions, oncologists continue to raise

Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Read More »

Patient-Doctor Perspectives: Groundbreaking Research in CML

5 Comments / Chronic myeloid leukemia, Clinical Trials, English, Episodes, Health Disparities

Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a patient and doctor. To celebrate the 100th episode of The Bloodline with LLS, we will be speaking with Mel Mann, a chronic myeloid leukemia (CML) survivor and Dr. Brian Druker, a physician researcher at Oregon Health Sciences University

Patient-Doctor Perspectives: Groundbreaking Research in CML Read More »

Clinical Trials in Lymphoma: An Evolution, Not A Revolution

2 Comments / Clinical Trials, English, Episodes, Lymphoma, Non-Hodgkin lymphoma

Join us as we speak to Dr. Grzegorz (Greg) Nowakowski, a physician researcher and Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, who also leads the Mayo Clinic Aggressive Lymphoma program. In this episode, Dr. Nowakowski discusses clinical trials for lymphoma patients, including recent advancements and how clinical trials work. He also discusses the benefits

Clinical Trials in Lymphoma: An Evolution, Not A Revolution Read More »

Scroll to Top